CD40LG and systemic lupus erythematosus: In a preliminary study in five patients with SLE a brief period of treatment with anti-CD40L markedly reduced the frequency of IgG and IgG anti-DNA antibody-producing B cells, and these changes persisted for several months after cessation of treatment [71].